Form 8-K Homology Medicines, Inc. For: Mar 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Homology Medicines Inc. (FIXX) Approves 1:18 Reverse Share Split
March 20, 2024 4:10 PM EDTAs previously reported on the Current Report on Form 8-K filed on March 15, 2024, the stockholders of Homology Medicines Inc. (NASDAQ: FIXX) at a Special Meeting of Stockholders (the Homology Special Meeting) previously approved an amendment to the Restated Certificate of Incorporation of Homology to effect a reverse stock split of Homologys issued and outstanding common stock at a ratio ranging from any whole number between 1-for-10 and 1-for-30, as determined by the Homology board of directors in its discretion, subject to the Homology board of directors authority to abandon such amendment.
The Homology... More
